Idorsia Ltd logo

Idorsia Ltd - Registered Shares

OTCPK:IDRSF (Switzerland)   Registered Shares
$ 2.25 0 (0%) 10:08 PM EST
At Loss
Market Cap:
$ 446.96M
Enterprise V:
$ 1.44B
Volume:
-
Avg Vol (2M):
940.00
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
940.00

Business Description

Description
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
Name Current Vs Industry Vs History
Cash-To-Debt 0.28
Equity-to-Asset -1.2
Debt-to-Equity -1.35
Debt-to-EBITDA -92.2
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.31
Distress
Grey
Safe
Beneish M-Score -0.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 3.56
9-Day RSI 21.77
14-Day RSI 34.7
6-1 Month Momentum % 17.94
12-1 Month Momentum % -68.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.14
Quick Ratio 1
Cash Ratio 0.84
Days Inventory 2180.16
Days Sales Outstanding 74.85
Days Payable 889.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4
Shareholder Yield % -3.38

Financials

IDRSF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:IDRSF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Idorsia Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 158.274
EPS (TTM) ($) -0.416
Beta 1.33
Volatility % 103.88
14-Day RSI 34.7
14-Day ATR ($) 0.025901
20-Day SMA ($) 2.335
12-1 Month Momentum % -68.53
52-Week Range ($) 1.4 - 8
Shares Outstanding (Mil) 179.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Idorsia Ltd Filings

Filing Date Document Date Form
No Filing Data

Idorsia Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Idorsia Ltd Frequently Asked Questions

What is Idorsia Ltd(IDRSF)'s stock price today?
The current price of IDRSF is $2.25. The 52 week high of IDRSF is $8.00 and 52 week low is $1.40.
When is next earnings date of Idorsia Ltd(IDRSF)?
The next earnings date of Idorsia Ltd(IDRSF) is .
Does Idorsia Ltd(IDRSF) pay dividends? If so, how much?
Idorsia Ltd(IDRSF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1